eFoodSafety to Attend International Conference on Avian Influenza

World Scientific Leaders and Experts Gather to Discuss Knowledge,
Experiences, and Expertise on Avian Influenza

Company's Citroxin(TM) Product Undergoing Testing in Thailand to
Eradicate Avian Influenza
SCOTTSDALE, Ariz.--(Business Wire)--eFoodSafety.com, Inc.'s (OTCBB: EFSF, www.efoodsafety.com)
representatives will attend the Bangkok International Conference on
Avian Influenza 2008, Integration from Knowledge to Control in Bangkok
from January 23-25. The conference, organized by the National Center
for Genetic Engineering and Biotechnology (BIOTEC), the National
Science and Technology Development Agency (NSTDA), and other related
organizations, aims to provide an international forum for scientific
experts and scientists to discuss avian influenza (bird flu) and to
facilitate international collaboration to mitigate threats from this
disease.

eFoodSafety's Citroxin(TM) is currently undergoing testing at
Chulalongkorn University, Thailand, on a chick embryo model, for the
product's ability to safely and effectively eradicate the most
virulent form of the bird flu, the H5N1 virus. Chulalongkorn
University is one of only a few labs in Asia used by the U.S. Centers
of Disease Control to conduct research on treatments of H5N1.

"We are looking forward to attending and participating in this
important conference, which addresses such a pertinent health concern
not only as it applies to the general population, but also as is
applies to eFoodSafety," says Timothy Matula, Director and Corporate
Secretary of eFoodSafety. "This is an opportune time to meet with
industry experts and share ideas about how to tackle this harmful
disease."

About eFoodSafety.com

eFoodSafety.com, Inc., based in Scottsdale, Arizona, is dedicated
to improving health conditions around the world through its innovative
technologies. The company's Knock-Out Technologies, Ltd. subsidiary
has developed an environmentally safe sporicidal product formulated
entirely of food-grade components that eradicates anthrax and a
germicidal product, Citroxin(TM) (formerly named Big Six Plus) - EPA
Reg. No. 82723-1 that kills six major bacteria: E-coli, Listeria,
Pseudomonas, Salmonella, Staphylococcus, and Streptococcus, Avian
Influenza, and Black Mold. The sporicidal product has completed its
final efficacy laboratory study requisite for EPA registration. In the
study, it eradicated both Clostridium Sporogenes and Bacillus Subtilis
with 100% efficacy on both hard and porous surfaces. The OraPhyte(TM)
product, which has been tested and shown to be effective at
eradicating nematodes by the U.S. Department of Agriculture, is
currently at three major universities with outstanding Agricultural
Departments undergoing crop-specific research.

The company's Cinnergen(TM) is a clinically-studied,
non-prescription liquid whole food nutritional supplement that
promotes healthy glucose metabolism, is available for sale at
(www.cinnergen.com) and through national retailers; its Cinnechol(TM)
is a multi-faceted nutritional supplement specifically designed to
naturally reduce total cholesterol levels without causing any side
effects. The company has entered into a joint venture agreement with
CK41 Direct, Inc. to launch the PurEffect(TM) anti-acne skin care
system.

The company's iBoost, Inc. subsidiary is the distributor of the
Immune Boost Bar(TM), a non-dairy, no refined sugar, all-natural and
comprehensive multi-nutrient product that helps fortify the body's
immune system. The product contains Citroxin(TM), eFoodSafety's
proprietary all natural supplement proven effective in fighting
several types of harmful bacteria, and forty active compounds that
assist with enhancing immunity, detoxification, cleansing, and
metabolic efficiency. The Immune Boost Bar(TM) is available in three
delicious flavors: chocolate, oatmeal-raisin, mint and peanut butter
and can be purchased at www.immuneboost.com.

The company's MedElite, Inc. subsidiary distributes clinically
proven products to physicians who then prescribe the products for
their patients. It is the owner of the Talsyn(TM)-CI/bid Scar Cream, a
product that has been clinically proven to facilitate and improve the
appearance, redness and strength of scars (www.talsyn.com), as well as
seven (7) other products in the Talsyn(TM) line.

Please visit the company's website at: http://www.efoodsafety.com.

Safe Harbor Forward-Looking Statements

Statements contained in this release that are not strictly
historical are "forward-looking statements." Such forward-looking
statements are sometimes identified by words such as "intends,"
"anticipates," "believes," "expects" and "hopes." The forward-looking
statements are made based on information available as of the date
hereof, and the Company assumes no obligation to update such
forward-looking statements. Editors and investors are cautioned that
such forward-looking statements involve risks and uncertainties that
could cause the Company's actual results to differ materially from
those in these forward-looking statements. Such risks and
uncertainties include but are not limited to demand for the Company's
products and services, our ability to continue to develop markets,
general economic conditions, our ability to secure additional
financing for the Company and other factors that may be more fully
described in reports to shareholders and periodic filings with the
Securities and Exchange Commission.

Redwood Consultants, LLC
Jens Dalsgaard, 415-884-0348
or
The Investor Relations Group
212-825-3210
Investor Relations:
Michael Crawford
mcrawford@investorrelationsgroup.com
Brett Foley
bfoley@investorrelationsgroup.com
Emily Hanan
ehanan@investorrelationsgroup.com
or
Media Relations:
Ambrose Aban
aaban@investorrelationsgroup.com
Susan Morgenbesser
smorgenbesser@investorrelationsgroup.com

Copyright Business Wire 2008